Literature DB >> 12777685

Brain repair and neuroprotection by serum insulin-like growth factor I.

Eva Carro1, Jose Luis Trejo, Angel Núñez, Ignacio Torres-Aleman.   

Abstract

The existence of protective mechanisms in the adult brain is gradually being recognized as an important aspect of brain function. For many years, self-repair processes in the post-embryonic brain were considered of minor consequence or nonexistent. This notion dominated the study of neurotrophism. Thus, although the possibility that neurotrophic factors participate in brain function in adult life was prudently maintained, the majority of the studies on the role of trophic factors in the brain were focused on developmental aspects. With the recent recognition that the adult brain keeps a capacity for cell renewal, although limited, a new interest in the regenerative properties of brain tissue has emerged. New findings on the role of insulin-like growth factor I (IGF-I), a potent neurotrophic peptide present at high levels in serum, may illustrate this current trend. Circulating IGF-I is an important determinant of proper brain function in the adult. Its pleiotropic effects range from classical trophic actions on neurons such as housekeeping or anti-apoptotic/ pro-survival effects to modulation of brain-barrier permeability, neuronal excitability, or new neuron formation. More recent findings indicate that IGF-I participates in physiologically relevant neuroprotective mechanisms such as those triggered by physical exercise. The increasing number of neurotrophic features displayed by serum IGF-I reinforces the view of a physiological neuroprotective network formed by IGF-I, and possibly other still uncharacterized signals. Future studies with IGF-I, and hopefully other neurotrophic factors, will surely reveal and teach us how to potentiate the self-reparative properties of the adult brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12777685     DOI: 10.1385/MN:27:2:153

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  73 in total

1.  Ageing, fitness and neurocognitive function.

Authors:  A F Kramer; S Hahn; N J Cohen; M T Banich; E McAuley; C R Harrison; J Chason; E Vakil; L Bardell; R A Boileau; A Colcombe
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

Review 2.  Insulin-like growth factors as mediators of functional plasticity in the adult brain.

Authors:  I Torres-Aleman
Journal:  Horm Metab Res       Date:  1999 Feb-Mar       Impact factor: 2.936

3.  Plasma insulin-like growth factor I and IGF binding protein 3 levels in patients with acute cerebral ischemic injury.

Authors:  S Schwab; M Spranger; S Krempien; W Hacke; M Bettendorf
Journal:  Stroke       Date:  1997-09       Impact factor: 7.914

4.  IGF-1 modulates N and L calcium channels in a PI 3-kinase-dependent manner.

Authors:  L A Blair; J Marshall
Journal:  Neuron       Date:  1997-08       Impact factor: 17.173

5.  Long-range signaling within growing neurites mediated by neurotrophin-3.

Authors:  S Chang; S V Popov
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

6.  GDNF acutely modulates excitability and A-type K(+) channels in midbrain dopaminergic neurons.

Authors:  F Yang; L Feng; F Zheng; S W Johnson; J Du; L Shen; C P Wu; B Lu
Journal:  Nat Neurosci       Date:  2001-11       Impact factor: 24.884

Review 7.  Nonsynaptic diffusion neurotransmission (NDN) in the brain.

Authors:  P Bach-y-Rita
Journal:  Neurochem Int       Date:  1993-10       Impact factor: 3.921

8.  Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus.

Authors:  M A Aberg; N D Aberg; H Hedbäcker; J Oscarsson; P S Eriksson
Journal:  J Neurosci       Date:  2000-04-15       Impact factor: 6.167

9.  The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis and in multiple sclerosis.

Authors:  I Torres-Aleman; V Barrios; J Berciano
Journal:  Neurology       Date:  1998-03       Impact factor: 9.910

10.  Phosphorylation and IGF-1-mediated dephosphorylation pathways control the activity and the pharmacological properties of skeletal muscle chloride channels.

Authors:  A De Luca; S Pierno; A Liantonio; C Camerino; D Conte Camerino
Journal:  Br J Pharmacol       Date:  1998-10       Impact factor: 8.739

View more
  34 in total

Review 1.  Potential for discovery of neuroprotective factors in serum and tissue from hibernating species.

Authors:  Austin P Ross; Kelly L Drew
Journal:  Mini Rev Med Chem       Date:  2006-08       Impact factor: 3.862

Review 2.  Aging of the brain, neurotrophin signaling, and Alzheimer's disease: is IGF1-R the common culprit?

Authors:  Luigi Puglielli
Journal:  Neurobiol Aging       Date:  2007-02-20       Impact factor: 4.673

3.  T-817MA, a neurotrophic agent, ameliorates the deficits in adult neurogenesis and spatial memory in rats infused i.c.v. with amyloid-beta peptide.

Authors:  Tatsuo Kimura; Phuong Thi Hong Nguyen; Son Anh Ho; Anh Hai Tran; Taketoshi Ono; Hisao Nishijo
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

4.  Insulin-like Signaling Promotes Glial Phagocytic Clearance of Degenerating Axons through Regulation of Draper.

Authors:  Derek T Musashe; Maria D Purice; Sean D Speese; Johnna Doherty; Mary A Logan
Journal:  Cell Rep       Date:  2016-08-04       Impact factor: 9.423

Review 5.  The many faces of insulin-like peptide signalling in the brain.

Authors:  Ana M Fernandez; Ignacio Torres-Alemán
Journal:  Nat Rev Neurosci       Date:  2012-03-20       Impact factor: 34.870

Review 6.  Exercise and brain health--implications for multiple sclerosis: Part 1--neuronal growth factors.

Authors:  Lesley J White; Vanessa Castellano
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

Review 7.  Growth factors as mediators of exercise actions on the brain.

Authors:  M Llorens-Martín; I Torres-Alemán; José L Trejo
Journal:  Neuromolecular Med       Date:  2008-02-20       Impact factor: 3.843

Review 8.  Physical activity and neuroprotection in amyotrophic lateral sclerosis.

Authors:  Mary E McCrate; Brian K Kaspar
Journal:  Neuromolecular Med       Date:  2008-02-20       Impact factor: 3.843

Review 9.  Treatment of dwarfism with recombinant human insulin-like growth factor-1.

Authors:  Michael B Ranke; Joachim Wölfle; Dirk Schnabel; Markus Bettendorf
Journal:  Dtsch Arztebl Int       Date:  2009-10-23       Impact factor: 5.594

10.  Distribution and localization patterns of estrogen receptor-beta and insulin-like growth factor-1 receptors in neurons and glial cells of the female rat substantia nigra: localization of ERbeta and IGF-1R in substantia nigra.

Authors:  Arnulfo Quesada; Horacio E Romeo; Paul Micevych
Journal:  J Comp Neurol       Date:  2007-07-01       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.